Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Serial Lipocalin 2 and Oncostatin M levels reflect inflammation status and treatment response in axial spondyloarthritis

Fig. 1

LCN2 or OSM levels in axSpA patients with single pathway involvement. a axSpA patients with undetectable OSM levels: LCN2 levels in patients with persistent (L++) vs transient (L+) vs normal LCN2 (Ln). b axSpA patients with detectable OSM but normal LCN2 levels: OSM levels in patients with persistent (O++) vs transient OSM (O+). The highest LCN2/OSM levels from the serial measurements of each patient were used for comparisons in the plots. One-way analysis of variance (ANOVA) followed by Bonferroni’s multiple comparison and Student’s t test were used to determine significance

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us